Home > Insider Trading > Filing (0001144204-10-036461)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1222244	Prourocare Medical Inc.	PUMD	Surgical & Medical Instruments & Apparatus (3841)	201212923

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1285927	David Koenig	20200 Cottagewood Road Deephaven MN US 55331		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.00001 Par Value	Acquisiton	2010-07-01	5,938	$1.60	81,852	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.00001 Par Value	1,875	Indirect	Shares held by Clinical Network Management Corp., of which reporting person is a managing officer
Common Stock, $0.00001 Par Value	26,571	Indirect	Shares held by Clinical Network Inc., of which reporting person is a managing officer

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock, $0.00001 Par Value	Stock Options	$11.33		2012-04-19	3,000	3,000	Direct
Common Stock, $0.00001 Par Value	Stock Options	$1.50		2016-09-29	50,000	50,000	Direct
Common Stock, $0.00001 Par Value	Warrants	$1.30	2010-07-11	2013-07-11	0	0	Direct
Cash	Promissory Note	$1.00		2010-07-11	0	0	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2012-04-19	3,000	3,000	Direct
2016-09-29	50,000	50,000	Direct
2013-07-11	0	0	Direct
2010-07-11	0	0	Direct

Footnotes

Currently exercisable.
Options shall vest on the latter of the date that the Company is cleared by the FDA to sell the ProUroScan System in the United States or the date the Company closes on an aggregate of $2,000,000 or more of incremental equity financing after the date of grant (including the exercise of existing warrants).
On June 11, 2010, the Company executed a promissory note in the principal amount of $65,000 with a maturity date of December 1, 2010, with interest to accrue daily and payable in Warrants through July 10, 2010. (the "Note"). Warrants will accrue at a rate of 333.333 shares of common stock per day up to a maximum warrant coverage of 10,000 shares of common stock per $13,000 original principal amount of Notes, which equals a maximum warrant of 50,000 shares of common stock with respect to the Note. After 30 days, the Note will bear interest payable in cash and Warrants representing the accrued interest will be issued at an exercise price of $1.30.
Issued to reporting person in lieu of cash fo accrued director's fees.